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ABSTRACT 
Abstract 
The thesis entitled "Search for natural antimicrobial and biologically 
active agents" is comprised of four chapters dealing with general introduction, 
antimicrobial screening of some compound Unani formulations, antimicrobial and 
biological activity of plants used as ingredients in Unani medicines and isolation and 
characterization of their phytoconstituents. 
Growing concern about health and physical fitness has booming impact on 
renaissance of the traditionally used medicines as fast acting synthetic drugs, often 
have side effects on human body. These old miracle plants have their existence as 
herbal drugs despite considerable advancements in medical sciences and have the 
key root of traditional medicine system. 
Chapter 1 deals the importance of medicinal plants and how they come in 
prominence in medicines through out the world. Impact of infectious diseases on 
human health, use of medicinal plants/phytoconstituents in infectious diseases and 
synergic action of phytomedicines has also been discussed in this chapter. 
Chapter 2 describes antimicrobial activity of some Unani drugs used for the 
treatment of various infectious diseases. These Unani drugs are manufactured and 
marketed by Dawakhana Tibbiya College, Aligarh Muslim University, Aligarh. 
The ethanolic extract of five Unani drugs (Qurs-e-Sartaan Kafoori, Qurs-e-
Suzak, Dawa-e-Dibba, Safoof-e-Bars and Safoof-e-Kharish) having multiple 
botanical ingredients with some chemical substances and substances of animal 
origin was studied for scientific evaluation for their antibacterial and antifungal 
activity by agar well diffusion method against the Escherichia coli, Salmonella 
typhimuriun (clinical isolates), Staphylococcus aureus, Brucella abortus S-19 
(standard strains) and a yeast Candida albicans, a clinical isolate. 
The antibacterial and antifungal activity was assessed by presence or absence 
of zone inhibition or zone diameter. The antibacterial and antifungal activity was 
observed against all the tested bacteria and yeast for all the tested drugs, except 
Safoof-e-Kharish which is not active against Escherichia coli and Salmonella 
typhimurium. Escherichia coli seem to be least sensitive towards these drugs as 
revealed by its zone diameter. 
In chapter 3 the antimicrobial activity and hepatoprotective effect of 
Operculina turpethum (roots) aqueous extract (OTE) have been discussed. 
Operculina turpethum, commonly known as trivrit or nishot, belongs to the Family 
Convolvulaceae, is of tremendous ethno-medicinal value. Mainly, roots or stem bark 
of this plant are traditionally used for medicinal purposes. 
The antimicrobial activity of the Operculina turpethum extract (OTE) were 
tested against some pathogenic microbes includes Salmonella typhimurium. Listeria 
monocytogenes, Candida albicans and Cryptococcus neoformans by micro dilution 
method. The results of the antimicrobial screening are highly encouraging. The 
Operculina turpethum extract (OTE) of the plant inhibits the growth of Candida 
albicans at the lowest concentration of 6.25 |ig/ml. 
The therapeutic effect of Operculina turpethum extract (OTE) against 
NDMA induced hepatotoxicity in rats was assessed by histological observations and 
biochemical parameters. 
Hepatic fibrosis was induced in adult male albino rats through serial 
intraperitoneal administrations of NDMA at a concentration of 10 mg/kg body 
weight on three consecutive days of each week over a period of three weeks. A 
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group of rats received Operculina turpethum extract (OTE) orally in doses of 75, 
150 and 200 mg/kg body weight at 5 hours after the administration of NOMA. The 
controls and treated animals were sacrificed on days-7, 14 and 21 after the start of 
the administration of NOMA. The progression of hepatic fibrosis as well as the 
amelioration effect of Operculina turpethum extract (OTE) was evaluated 
histopathologically as well as by immunohistochemical staining for the activation of 
hepatic stellate cells. Alterations in serum and liver biochemical parameters and 
LDH isoenzymes were also studied. Serial administration of NDMA resulted in well 
formed fibrosis in the liver. Staining of a-SMA demonstrated activated stellate cells 
from day-7 onwards which was dramatically increased on day-21. An elevation of 
liver function enzymes, serum hydroxyproline levels and LDH isoenzymes 4 and 5 
were also observed. All these changes were remarkably reduced in Operculina 
turpethum extract (OTE) administered animals and fibrogenesis was completely 
absent. Our results suggest that Operculina turpethum extract (OTE) has 
hepatoprotective effects against NDMA-induced hepatic fibrosis. 
In chapter 4 antimicrobial activity and isolation and characterization of the 
constituent of Acacia leucophloea Willd. (stem bark) have been discussed. The 
antimicrobial activity of the fractions of ethanolic extract of the stem bark of Acacia 
leucophloea Willd. were tested by micro dilution method against the two bacteria 
and two fungi. Acetone fraction showed significant activity at 6.25 ng/ml against 
Candida albicans while the minimum inhibitory concentration of ethyl acetate 
fraction in Salmonella typhimurium and Candida albicans was 12.5 ^g/ml. 
The ethyl acetate fraction of ethanolic extract was adsorbed on silica gel and 
passed over a column of silica gel set with petroleum ether. The column was eluted 
with mixture of solvents increasing order of polarity and the fractions were mixed 
together on the basis of TLC pattern. The antimicrobial activity of these fractions 
was tested also by the same protocol against the same microorganisms described 
above. These fractions showed activity against all the tested microorganisms. 
The ethyl acetate eluent of the column chromatography affords a compound 
which is identified as a phenolic trimer (A-4) on the basis of spectral analysis 
(MASS, 'H-NMR '^C-NMR). 'H-NMR spectra of the compound was complex 
therefore the compound was further purified by preparative HPLC using C-18 
column. This pre-purified compound was analyzed by UPLC-MS for purity using 
gradient system. 
This chapter also includes comprehensive review of constituents isolated 
from the different part of the plant. 
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CHAPTER-1 
GENERAL INTRODUCTION 
1. Introduction 
Medicinal plants have always been crucial in sustaining the health and well 
being of mankind. Since time immemorial, traditional systems of medicine have 
been practiced by man to cure various ailments. These traditional system of 
medicine largely depended on medicinal and aromatic plants, a fact that can be 
traced back from Vedas and Charak Samhita. Even today, many people rely on the 
use of these plants for treating different diseases especially in the rural areas where 
health facility is scarce. Moreover, growing concern about health and physical 
fitness has provided a booming impact on renaissance of traditional medicines as 
fast acting synthetic drugs, often have side effects on human body. 
Population rise, inadequate supply of drugs, prohibitive cost of treatments, 
side effects of several allopathic drugs and development of resistance to currently 
used drugs for infectious diseases have led to increased emphasis on the use of plant 
materials as a source of medicines for a wide variety of human ailments [Joy et al., 
2001]. There is no exact data available to assess the value and extent of the use of 
plants or of active constituents derived from them in the health care systems. It has 
been estimated by the World Health Organization (WHO) that approximately 80 % 
of the more than 4000 million inhabitants of the world rely mainly on traditional 
medicines for their primary health care [Famsworth, 1985]. 
In spite of the overwhelming influences and our dependence on modem 
medicine and tremendous advances in synthetic drugs, a large segment of the world 
population still like drugs from plants. In many of the developing countries the use 
of plant drugs Is increasing because modem life saving drugs are beyond the reach 
of three quarters of the third world's population although many such countries spend 
40-50% of their total wealth on drugs and health care. As a part of the strategy to 
reduce the financial burden on developing countries, it is obvious that an increased 
use of plant drugs will be followed in the future [Joy et al., 2001]. 
Estimates indicate that approximately one quarter of prescribed drugs contain 
plant extracts or active ingredients obtained from or modeled on plant substances. 
According to UNDP report, the annual value of medicinal plants derived from 
developing countries is approximately 32 billion US dollars. There are 47 major 
modem pharmaceutical plant based drugs already present in the world market and 
the predicted 328 drugs are yet to be discovered, having market potential of 147 
billion US dollars. The most popular analgesic, aspirin, was originally derived from 
species of Salix and Spiraea and some of valuable anti-cancer agents such as 
paclitaxel and vinblastine are derived solely from plant sources [Tripathi and 
Tripathi, 2003]. 
It is estimated that there are 250,000 to 500,000 species of plants on Earth 
[Borris, 1996]. A relatively small percentage (1 to 10%) of these are used as food by 
humans and also eaten by other animal species. It is possible that even more are used 
for medicinal purposes [Moerman, 1996]. Hippocrates (in the late fifth century B.C.) 
mentioned 300 to 400 medicinal plants [Schultes, 1978]. In the first century A.D., 
Dioscorides wrote De Materia Medica, a medicinal plant catalog which became the 
prototype for modem pharmacopoeias. The Bible offers descriptions of 
approximately 30 healing plants. Indeed, frankincense and myrrh probably enjoyed 
their status of great worth due to their medicinal properties. Reported to have 
antiseptic properties, they were even employed as mouthwashes. The fall of ancient 
civilizations forestalled Westem advances in the understanding of medicinal plants, 
with much of the documentation of plant pharmaceuticals being destroyed or lost 
[Stockwell, 1988]. During the Dark Ages, the Arab world continued to excavate 
their own older works and to build upon them. Of course, Asian cultures were also 
busy compiling their own pharmacopoeia. In the West, the Renaissance years saw a 
revival of ancient medicine, which was built largely on plant medicinals. 
To understand exactly the usage of drugs of plant origin and other origins, as 
to how they come into prominence in medicine through out the world. It is necessary 
to go through the developmental history of these drugs. This will help not only to the 
students, research scholars, and the workers engaged in this field but also physicians 
as well. 
The history of drug usage goes back to the prehistoric era. Basically there are 
three schools of medicine in the world. These schools can be assigned to utilize the 
drugs of the plants, mineral and animal origin for curing different type of ailments in 
different ways with a difference of few hundred years of development of this 
knowledge, simultaneously. These three schools are Chinese School of medicine 
(2,735 B.C.) in East, Indian school of medicine (4,500- 1,600 and 2,500 - 600 B.C.) 
and Greek School of medicine (460 B.C.) in West respectively [Khan, 1981]. Early 
records show that the interaction of Greeks, Egyptian and Arabs led to the 
emergence of Egyptian medicines, Arab medicines and Unani medicines [Khan, 
1981]. 
1.1. Chinese medicine 
The Chinese material medica has been extensively documented over the 
centuries with the first record dating from about 1100 B.C. (Wu Shi Er Bing Fang, 
containing 52 description) followed by work such as the Shennong herbal (~ 100 
B.C.; 365 drugs), and the Tang herbal (~ 659 A.D.; 850 drugs) [Crag and Newman, 
2002]. The Chinese medicine are compiled in the form of pharmacopoeia called 
"Pun Tsao" in Chinese or the "Great Herbal" having 40 volumes describing 
thousands of preparations [Khan, 1981]. 
1.2. Indian medicine (Ayurveda) 
The Vedas are the earliest sacred book of the Hindu mythology. There are 
four Vedas; Rigveda, Saumveda, Yajurveda and Atharvaveda. [Khan, 1981]. The 
origin of Ayurveda is generally traced to the Atharavaveda (fc^  1000 BC) which has 
details of what may be called religious or priestly medicine similar to early Egyptian 
medicine. An important aspect of Vedic medicine was the use of certain plants as 
amulets, apart from their use either in the form of decoction or powder or fumigant 
as medicines [Subbarayappa, 2001]. 
About 8,000 herbal remedies have been codified in Ayurveda. The Rigveda 
(5000 BC) has recorded 67 medicinal plants, Yajurveda 81 species, Atharvaveda 
(4500-2500 BC) 290 species, Charak Samhita (700 BC) and Sushrut Samhita (200 
BC) had described properties and uses of 1100 and 1270 species respectively, in 
compounding of drugs and these are still used in the classical formulations, in the 
Ayurvedic system of medicine [Joy et al., 2001]. 
1.3. Egyptian medicine 
In the west, before the advent of Greek medicine records, the drugs usages 
are also available in the form of Egyptian Materia-Medica [Khan, 1981]. Egyptians 
used medicinal herbs from nearly 2900 B.C and the best knowledge of Egyptian 
Materia-Medica comes from two papyri, the Edwin Smith Papyrus of ca. 1600 B.C. 
and the Ebers Papyrus of ca. 1500 B.C. [Bryan, 1930., Crag and Newman, 2002]. 
Egyptian medicine was essentially a belief system. It was believed that there 
were thirty six gods of the atmosphere and thirty-six 'demons', and the human body 
was conceptually divided into as many parts. If a part of the body was affected, the 
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concerned 'demon' had to be invoked for its cure. The concept of disease-demons 
was very strong among Egyptians. Though plant medicaments were in use, they 
were not considered to be efficacious without the appeasement of 'demons' through 
magical rites [Subbarayappa, 2001]. Medicine and superstitious teleology were as a 
two-in-one pair among Egyptian priests [Guthrie, 1920]. 
1.4. Greek medicine 
The Greek system of medicine originated in ancient Greece around 1250-285 
B.C. [Mouhajir, 2002]. In the early days, Greek medicine was closely linked with 
religion. Apollo, the Sun- God was considered to be the protector of mankind from 
the attack of epidemics such as plague. The practice of the sick visiting temples of 
Aesculapius became popular and deep-rooted in Greek society around 1000 BC 
[Subbayarapa, 2001]. It was in essence a faith cure and sick person offering prayers 
and animal sacrifices in the temple were a common feature. 
However, by about 500 B.C. medicine began to be separated from the 
magical and spiritual world. Hippocratus (460-377 B.C.), the Greek "Father of 
medicine" considered illness to be a natural rather than a supernatural phenomenon 
and he felt that medicine should be given without ritual ceremonies or magic 
[Andrew, 1996]. Hippocratic collection shows evidence of new medical ethics and a 
scientific sprit [Chadwick and Mann, 1950]. More than 4000 drugs are mentioned in 
his work. Important work by Theophrastus (370-285 B.C.) includes "Historia 
plantarum" or "Enquiry into plants" which contain information about the collection 
and preparation of vegetable drugs such as peony roots, food stuffs, perfumes, plant 
diseases and weather sign [Mouhajir, 2002]. 
1.5. Arab medicine 
In the period of golden age of the Muslims (A.D. 632-1150) the Arabs 
having conquered Egypt, Syria, Iraq and Persia extended their empire from the 
border of India to Spain [Mouhajir, 2002]. Several treatises dealing with what is 
called Prophetic medicine were compiled by clerics engaged in the traditional 
medical practices during the time of Prophet Mohammad [Subbayarappa, 2001]. The 
concepts and contents relating to material medica and therapeutics of the Muslims in 
the period from 750 A.D. to about 1350 were qualitatively and quantitatively far 
ahead of those of preceding cultures. In quantity, the number of simple and 
compound remedies rose to about 4,000 which is a fantastic number compared with 
the mere hundreds in the Greek words [Mouhajir, 2002]. In addition, there emerged 
a school of medicine followed by foundation of centers of learning where scholars 
were encouraged to translate and incorporate other influential works of the time into 
their own knowledge, findings and experience. 
Apart from the systematizing the pharmacogical knowledge of Greeks, 
Persian and Babylonians, many highly specialized treatises were compiled by the 
Arabs where in genuinely original contributions to enhance the knowledge of the 
medical Materia-Medica were made. The Arabic pharmacology lasted into the 
nineteenth century as the strongest fact- based biological sciences [Mouhajir, 2002]. 
1.6. Greco - Arab system of medicine (Unani) 
The system which originated in Greece and developed by Arabs into an 
elaborate medical science on the basis of teaching of Hippocrates, Descroids and 
Gallenics called Greco- Arab system of medicine which later on after centuries came 
down to India with Muslim advents and flourished with the name Unani system of 
medicine [Khan, 1981]. With the patronage of Muslim kings, the Unani medicine 
flourished specially under the Mughal Empire. Its Materia-Medica includes mostly 
herbal drugs, besides some of animal and mineral origin [Subbayarappa 2001]. 
1.7. Indian medical trinity of traditional medicines 
Indian subcontinent has been reputed as the treasure of valuable medicinal 
plants of the world on account of vast diversity of climatic conditions and India 
enjoys the privilege of having time tested traditional systems of medicines based on 
the natural products. Plant based products have been in use for medicinal, 
therapeutic or other purposes right from the dawn of history. Additionally, India is 
one of the 12-mega biodiversity centers having about 10% of the world's 
biodiversity wealth, which is distributed across 16 agro-climatic zones. Out of 
17,000 species of higher plants reported to occur within India, 7500 are known to 
have medicinal uses. This proportion of medicinal plants is the highest known in any 
other country against the existing flora of the country. Currently, approximately 
25% of drugs are derived from plants, and many others are synthetic analogue buih 
on prototype compounds isolated from plant species in modem pharmacopoeia 
[Ahmad, 2008]. 
Of the Indian medical trinity - Ayurveda, Unani and Siddha - Ayurveda has 
its roots in Vedic literature, while Unani, which is Greco-Arabic medicine, owes its 
origin to Central and West Asia. Neither of them, however had any alchemical 
undertone. The Siddha system was regionally confined to Tamil Nadu and its 
adjoining areas among Tamil-speaking people [Subbarayappa, 1997]. These systems 
of medicines (Ayurveda, Unani and Siddha) have a number of drugs in common, 
though they are of different origin, and source. These drugs even now are identified 
with different vernaculars and common names though the botanical identity is one 
and the same. Similar is the case with mineral and animal origin [Khan, 1981]. 
1.8. Infectious Diseases 
Infectious diseases are the leading cause of premature death, killing almost 
50,000 people every day through out the world [Ahmad and Beg, 2001]. Infectious 
diseases claim almost half of the deaths in tropical countries. In recent years, this 
trend seems to be increasing even in developed countries [Iwu et al., 1999]. Not 
surprising death from infectious disease, ranked 5th in 1981, has become the 3rd 
leading cause of death in 1992, an increase of 58% [Pinner et al., 1996]. 
This is alarming given that it was once believed that we would eliminate 
infectious disease by the end of the millenium. The increases are attributed to 
increases in respiratory tract infections and HIV/AIDS. Other contributing factors 
are an increase in antibiotic resistance in nosicomial and community acquired 
infections. Furthermore, the most dramatic increases are occurring in the 25-44 year 
old age group [Pinner et al., 1996]. 
These negative health trends call for a renewed interest in infectious disease in the 
medical and public health communities and renewed strategies on treatment and 
prevention. Proposed solutions are outlined by the CDC as a multi-pronged 
approach that includes: prevention, (such as vaccination); improved monitoring; and 
the development of new treatments. It is this last solution that would encompass the 
development of new antimicrobials [Fauci, 1998]. 
Indiscriminate use of antibiotics and drug resistant of human pathogenic 
microorganisms continue to be an area of concern [Ahmad and Beg, 2001]. 
The substance that can either inhibit the growth of pathogen or kill them and 
have no or least toxicity to host cell are considered candidates for developing new 
anti microbial drugs. (In recent years antimicrobial property of medicinal plants are 
being increasingly reported from different parts of the world [Grosvener et al., 1995; 
Ratnakar and Murthy, 1995; Silva, 1996; David, 1997; Saxena, 1997; Nimri et al., 
1999; Saxena and Sharma, 1999]. 
1.9. Medicinal plants as Antimicrobials 
Plants have provided a good source of inspiration for novel drug compounds. 
New drugs are still being derived from a wide variety of medicinal plants. These 
drugs may serve as antimicrobial agents and inhibit disease causing pathogens and 
have made large contributions to human health and well-being. The role of these 
medicinal plants in the development of new drugs is two fold VIZ. (1) they may 
become the base for the development of a medicine, a natural blueprint for the 
development of new drugs, or; (2) a phytomedicine to be used for the treatment of 
disease. There are numerous illustrations of plant derived drugs [Iwu et al., 1999]. 
Some selected examples, including those classified as anti-infective, are described 
below. 
The isoquinoline alkaloid emetine obtained from the underground part of 
Cephaelis ipecacuanha, and related species, has been used for many years as an 
amoebicidal drug as well as for the treatment of abscesses due to the spread of 
Escherichia histolytica infections. Another important drug of plant origin with a 
long history of use is quinine. This alkaloid occurs naturally in the bark of Cinchona 
tree. Apart from its continued usefiilness in the treatment of malaria, it can be also 
used to relieve nocturnal leg cramps. Currently, the widely prescribed drugs are 
analogs of quinine such as chloroquine. Some strains of malarial parasites have 
become resistant to the quinines; therefore, antimalarial drugs with novel mode of 
action are required. 
Similarly, higher plants have made important contributions in the areas 
beyond antiinfectives, such as cancer therapies. Early examples include the 
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antileukaemic alkaloids, vinblastine and vincristine, which were both obtained from 
the Madagascan periwinkle {Catharanthus roseus syn. Finca roseus) [Nelson, 
1982]. Other cancer therapeutic agents include taxol, homoharringtonine and several 
derivatives of camptothein. For example, a well-known benzylisoquinoline alkaliod, 
papaverine, has been shown to have a potent inhibitory effect on the replication of 
several viruses including cytomegalovirus, measles and HIV [Turano et al., 1989]. 
Most recently, three new atropisomeric naphthylisoquinoline alkaloid dimers, 
michellamines A, B, and C were isolated from a newly described species tropical 
liana Ancistrocladus korupensis from the rainforest of Cameroon. The three 
compounds showed potential anti-HIV with michellamine B being the most potent 
and abundant member of the series. These compounds were capable of complete 
inhibition of the cytopathic effects of HIV-1 and HIV-2 on human lymphoblastoid 
target cell in vitro [Boyd et al., 1994]. 
Plants have an almost limitless ability to synthesize aromatic substances, 
most of which are phenols or their oxygen-substituted derivatives [Geissman, 1963]. 
Most are secondary metabolites, of which at least 12,000 have been isolated, a 
number estimated to be less than 10% of the total [Schultes, 1978]. In many cases, 
these substances serve as plant defense mechanisms against predation by 
microorganisms, insects, and herbivores. Some, such as terpenoids, give plants their 
odors; others (quinones and tannins) are responsible for plant pigment. Many 
compounds are responsible for plant flavor (e.g., the terpenoid capsaicin from chili 
peppers). 
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There are still some plant based drugs for which no synthetic alternative is 
available listed in table below [Kumar et a!., 1997]. 
Drug 
Vinblastine 
Ajmalacine 
Rescinnamine 
Reserpine 
Quinine 
Pilocarpine 
Cocaine 
Morphine 
Codeine 
Atropine 
Atropine 
Cardiac glycosides 
Artemisinin 
Taxol 
Berberine 
Pristimerin 
Quassinoids 
Plumbagin 
Diospyrin 
Gossypol 
Plant 
Catharanthus roseus 
Catharanthus roseus 
Rauvolfia serpentina 
Rauvolfia serpentina 
Cinchona sp. 
Pilocarpus jaborandi 
Erythroxylum coca 
Papaver somniferum 
Papaver somniferum 
Atropa belladonna 
Hyoscyamus niger 
Digitalis sp. 
Artemesia annua 
Taxus baccata 
T. Brevifolia 
Berberis 
Celastrus paniculata 
Ailanthus 
Plumbago indica 
Diospyros montana 
Gossypium sp. 
Use 
Anticancer 
Anticancer, hypotensive 
Tranquilizer 
Tranquilizer 
Antimalarial, amoebic 
dysentery 
Antiglucoma 
Topical anaesthetic 
Painkiller 
Anticough 
Spasmolytic, cold 
Spasmolytic, cold 
For congestive heart 
failure 
Antimalarial 
Breast and ovary cancer 
Antitumour 
For leishmaniasis 
Antimalarial 
Antiprotozoal 
Antibacterial, antifungal 
-O 
< 
Antispermatogenic 
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Allicin 
Ricin 
Emetine 
Glycyrrhizin 
Nimbidin 
Catechin 
Sophoradin 
Magnolol 
Forskolin 
Digitoxin, 
Thevenerin, 
Nerrifolin 
Podophyllin 
Indicine N-oxide 
Elipticine 
Homoharringtonine 
Camptothecine 
Allium sativum 
Ricinus communis 
Cephaelis ipecacuanha 
Glycyrrhizia glabra 
Azadirachta indica 
Acacia catechu 
Sophora subprostrata 
Magnolia bark 
Coleus forskohlii 
Digoxin Digitalis, 
Thevetia 
Thevetia 
Thevetia 
Podophyllum emodi 
Heliotropium indicum 
Ochrosia 
Cephalotaxus 
Camptotheca acuminate 
Antifungal, amoebiasis 
•Yf^y\ I 
Amoebiasis 
Antiulcer 
Antiulcer 
Antiulcer 
'.Antiulcer / 
Peptic ulcer 
Hypotensive, cardiotonic 
Cardio tonic 
Cardio tonic 
Cardio tonic 
Anticancer 
Anticancer 
Anticancer 
Anticancer 
Anticancer 
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BasicEilly the drugs of the Indian systems of medicines (Ayurveda, Unani and 
Siddha) are used either singly or in combination of various formulations. A number 
of plants used medicinally in our systems have been chemically analyzed as evident 
from the published work in our country as well as abroad. We should now try them 
pharmacologically and clinically to prove the efficacy of the exact, effective and 
active chemical constituents. The pharmacological testing of the crude drugs (used 
in various formulations) can not be done unless each and every single drug yielding 
plant is identified botanically, pharmacogonostically and chemically and then put in 
pharmacological and clinical trials [Khan, 1981]. 
1.10. Synergistic action of Phytomedicines 
In comparison to synthetic drugs based upon single chemicals, many 
phytomedicines exert their beneficial effects through the additive or synergistic 
action of several chemical compounds acting at single or multiple target sites 
associated with a physiological process [Briskin, 2000]. Synergistic or additive 
pharmacological effect can be beneficial by eliminating the problematic side effects 
associated with the predominance of a single xenobiotic compound in the body 
[Tyler, 1999]. How synergistic interactions underlie the effectiveness of a number of 
phytomedicines are extensively documented [Kaufman et al., 1999]. This theme of 
multiple chemicals acting in an additive or synergistic manner likely has its origin in 
the functional role of secondary products in promoting plant survival. For example, 
in the role of secondary products as defense chemicals, a mixture of chemicals 
having additive or synergistic effects at multiple target sites would not only ensure 
effectiveness against a wide range of herbivores or pathogens but would also 
decrease the chances of these organisms developing resistance or adaptive responses 
[Kaufman et al., 1999; Wink, 1999]. 
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1.11. Objectives of the thesis 
The indiscriminate use of allopathic daigs has developed resistant pathogens. 
Therefore, there is revival of interest in drugs of herbal origin. The aim of the 
present investigations is as follows: 
1. Scientific evaluation of some herbal drugs of Unani origin for 
antibacterial and antifungal activity. 
2. Antimicrobial activity and hepatoprotective effects of Operciilina 
turpethum. 
3. Investigations on Acacia leiicophloea Willd. 
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SCIENTIFIC EVALUATION 
OF SOME HERBAL DRUGS 
OF UNANI ORIGIN 
=OR ANTIBACTERIAL ANE 
ANTIFUNGAL ACTIVITY 
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2. Introduction 
Medicinal plants were extensively used by the old civilizations through out 
the world. Chapter one describes that Egyptians used medicinal herbs from nearly 
2900 B.C. and the best known Egyptian Pharmaceutical record is the "Edwin Smith 
papyrus" and "Ebers Papyrus" dating from ca. 1600 B.C and ca. 1500 B.C. 
respectively [Bryan, 1930; Cragg and Newman, 2002] which documents 700 drugs 
(mostly of plants), and include formula such as, gargles, snuffs, poultices, infusions, 
pills and ointments with beer, milk, wine and honey being commonly used as 
vehicle. These ethno-medicinally important botanicals and their products now exist 
as herbal drugs despite considerable advancement in medical sciences. 
Increasing awareness on health and physical fitness has been putting pressure 
on herbal foimiulations as fast acting synthetic drugs have many side effects on 
human body. Keeping in view the growing demand of herbal drugs, industries are 
now engaged in developing new products prepared from natural products or 
substances of animal origin. As an alternative to synthetic drugs which show 
resistance to pathogens, herbal formulations are globally acceptable and hence have 
set stage for revival of traditional medicine. Recently, it has been demonstrated that 
many human pathogenic bacteria have developed resistance against several synthetic 
drugs [Piddock and Wise, 1989; Singh et al., 1992; Mulligen et al., 1993; Davis 
1994; Robin etal., 1998]. 
Available reports on lesser efficacy and more side effects of synthetic drugs 
have mobilized the masses to search alternative methods [Jain, 1991; Kumar et al., 
1997]. Conversely, the use of herbal drugs have proven promising in treating many 
genetic, biochemical or physiological alterations of human body with least or no side 
effects [Ahmad et al., 2008]. Moreover, recent researches on the prolong use of 
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ethno medicinal botanicals in crude form or their purified compounds have also 
shown certain side effects and suggested for their limited use [Kumar et al., 1997; 
Ahmad et al., 2008]. Therefore, it is necessary to re-evaluate the action and efficacy 
of the commercially available formulations which are in use for centuries. 
As mention in chapter 1, the Unani system of medicine has its roots in the 
Greek system of medicine, developed and propagated by Arabs. It came to India 
with the advent of Muslim rulers flourishing specially under the Mughal Empire. 
According to Unani, the human body and its health are constituted of seven 
components: elements (Al-Arkan), temperament (Al-Mizaj), four humours (Al-
Akhlat), organs (Al-A 'da), vital spirit (Al-Arwah), faculties (Al-Quwa) and functions 
(Al- Afal). The Unani concept of elements is that of Empedocles (5th century BC) -
earth, fire, water and air with their four primary qualities: hot, cold, dry and moist 
[Subbarayappa, 2001]. Its materia medica includes mostly herbal drugs, besides 
some of animal and mineral origin. The Unani concept of temperament has its own 
originality and even drugs are supposed to have their temperament according to 
which they are classified. 
In the present study efforts are made for scientific evaluation of five Unani 
drugs which are used commonly against bacterial and fungal infections in humans. 
These Unani drugs are Qurs-e-Sartaan Kafoori, Qurs-e-Suzak, Dawa-e-Dibba, 
Safoof-e-Bars and Safoof-e-Kharish. These Unani drugs manufactured and marketed 
by Dawakhana Tibbiya College, Aligarh Muslim University, Aligarh, have multiple 
botanical ingredients in addition to some chemical substances and substances of 
animal origin. The constitution of the selected drugs is summarized in tables 2.1 to 
2.5, while other details are given below: 
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Qurs-e-Sartaan Kafoori [Hakim Kabiruddin, 1932] 
Ingredients: Table-2.1 
Action: Styptic, Antipyretic 
Therapeutic use: Phthisis, Tuberculosis, Hectic fever 
Dose: 2 to 4 gm 
Qurs-e-Suzak [Patent] 
Ingredients: Table-2.2 
Action: Cicatrizant, Diuretic 
Therapeutic use: Gonorrhea 
Dose: Two tablets daily 
Dawa-e-Dibha [Patent] 
Ingredients: Table-2.3 
Action: Purgative 
Therapeutic use: Infantile Bronchopneumonia, Constipation 
Dose: 125 mg 
Safoof-e-Bars [Hakim Kabiruddin, 1932] 
Ingredients: Table-2.4 
Action: Blood purifier 
Therapeutic use: Vitiligo/Leucoderma, Pruritis/Itching 
Method of application: 10 gm of powder soaked in 50 ml of water over 
night. The infusion is decanted and orally administered in the morning. The 
sediment is mixed with sirka naishakar to prepare a paste and applied on the 
affected part, which are exposed to the sunrays. 
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Safoof-e-Kharish [Patent] 
Ingredients: Table -2. 5 
Action: Soothing agent 
Therapeutic use: Itching (For external use only) 
Method of application: Mix with Jasmine oil and apply on the affected 
portion. 
2.1. Materials and Methods 
The selected Unani drugs were purchased from the Dawakhana Tibbiya 
College, Aligarh Muslim University, Aligarh. The constitution of these drugs is 
summarized in Tables 1-5 while their dosage details and method of application have 
been described in the Introduction. 
2.1.1. Preparation of Drug extract 
5 gm of each drug were soaked in 50 ml of absolute alcohol for 70 to 80 hrs. 
Each extract was stirred every 10 to 12 hrs using a sterile glass rod and filtered 
through Whatman filter paper No. 1. The alcoholic extract obtained was 
concentrated on water bath at 40 "C. The extracts were stored at 4 °C for further use. 
The amount of the extract obtained from 5 gm of each drug is given in Table-2.6. 
2.1.2. Microorganisms used 
The test organisms Escherichia coli, Salmonella typhimurium, Candida 
albicans (Clinical isolates) and Staphylococcus aureus (Standard strain) were kindly 
gifted by Prof Abida Malik, Department of Microbiology, Jawaharlal Nehru 
Medical College and Hospital, A.M.U, Aligarh, India. Brucella abortus S-19 
(Standard strain) was procured from IVRI Bareilly. 
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2.1.3. Culture media 
The medium used for the activation of microorganisms was soyabean casein 
broth. For antimicrobial test the microbes were grown on different agar media. 
Escherichia coli and Salmonella typhimurium were grown on Mc Conky's medium 
while S. aureus, B. abortus S-19 and the fungus C. albicans on Nutrient agar, Luria 
Bertani (LB) and Yeast extract, peptone, dextrose (YPD) medium respectively. All 
culture media were prepared and treated according to the manufacturer's guidelines 
(Hi-media Pvt. Ltd. India). 
2.1.4. Inoculum 
The microorganisms were inoculated into Soyabean Casein Broth (SBCB) 
and incubated at 35 ± 2 "C for 4 hours. The turbidity of the resulting suspension was 
diluted with SBCB to obtain a transmittance of 25% at 580 nm. That percentage was 
found spectrophotometrically comparable to I Mc Farland turbidity standard. The 
level of turbidity is equivalent to approximately 3.0x10* CFU/ml. 
2.1.5. Agar diffusion assay 
The modified agar well diffusion method of Perez et al. [Perez et al., 1990] 
was employed. Microorganisms suspended in SBCB were inoculated in selective 
media. Once the agar was solidified, it was pinched for eight-millimeter diameter 
wells and filled with 100 jil (~ 10 mg crude extract) and 200 ]i\ (~ 20 mg crude 
extract) drugs extracts and blanks (ethanol 98% and distilled water) in separate 
wells. The concentration of extracts employed was 100 mg/ml. For positive control 
Gentamycin Sulphate (Brucella abortus S-19, Escherchia coli) Chloramphenicol 
{Salmonella typhimuriun, Staphylococcus aureus) and Amphotericin B {Candida 
albicans) were used. The tests were carried out in triplicate. The plates were 
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incubated at 35 ± 2 ''C for 24 hrs, except Candida albicans, which was incubated at 
29 ± 2 °C. 
2.2. Results 
The results of the antibacterial and antifungal screening of the tested drugs 
are shown in table- 2.7 and 2.8. The potency of the drugs was assessed by the 
presence or absence of zone inhibition or zone diameter. Among the tested drugs 
Safoof-e-Bars, Qurs-e-Suzak and Dawa-e-Dibba showed activity against all the 
tested bacteria and yeast, Candida albicans. 
While Safoof-e-Kharish did not show activity against S. typhimurium and E. 
coli and Qurs-e-Sartaan Kafoori against S. aureus respectively. 
Among the five tested microorganisms i.e. E. coli, S. typhimuriun, S. aureus, 
B. abortus S-19 and yeast Candida albicans. E. coli seems to be the least sensitive 
towards theses drugs as revealed by its zone diameter. 
Safoof-e-Bars showed good inhibition zone against B. abortus S-19, S. 
aureus, and Candida albicans. While Qurs-e-Suzak showed good inhibition zone 
against S. aureus,. B. abortus S-19, S. typhimurium and S. aureus. Qurs-e-Sartaan 
Kafoori showed good inhibition zone against B. abortus S-19 and S. aureus. Dawa-
e-Dibba showed good inhibition zone against S. aureus, B. abortus S-19 and 
Candida albicans while Safoof-e-Kharish shows good activity against B. abortus S-
19 and S. aureus. 
2.3. Discussion 
With the changing perception and attitude towards the use of synthetic drugs, 
industries are encouraged to replace them with some suitable alternative and the 
Unani formulations are witnessing this change. Compared with various methods 
being used to ameliorate the common ailments, method of treating with some 
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friendly and effective natural compounds is preferred [Ahmad et al., 2008]. The 
present study on antimicrobial activity of five Unani drugs (ethanolic extract) having 
multiple botanical ingredients along with some chemical substances and molecules 
of animal origin and commonly used for the treatment of various infectious diseases 
revealed good results. We have tested their activity against four pathogenic bacteria 
Salmonella typhimuhum, Brucella abortus S-19, Escherchia coli. Staphylococcus 
aureus and one pathogenic yeast Candida albicans. This is the first report describing 
antimicrobial activity of Unani formulations involved in the treatment of infectious 
disease. 
We have taken the ethanolic extract of the drugs, as published literature 
suggests suitability of alcohol as the better solvent for the extraction of antimicrobial 
substances as compared to water or hexane [Ahmad and Beg 2001]. The 
antibacterial and antifungal efficacy as well as the potency of the extracts of the 
drugs was quantitatively assessed by the presence or absence of zone of inhibition or 
zone diameter (Table- 2.7 and 2.8). Our results are highly encouraging and showed 
activity of all the five extracts of the drugs against the tested bacteria and selected 
yeast, C. albicans. The only exception was the ethanolic extract of Safoof-e-Kharish 
which did not show any activity against S. typhimurium and E. coli. Qurs-e-Sartaan 
Kafoor against S. aureus. 
Among the microorganisms used, the only exception is E. coli which showed 
least sensitivity against the drugs tested. Therefore, it can be inferred that the 
importance of the selected Unani drugs becomes least while treating disease 
occurred by E. coli infection. As indicated in table 2.7- 2.8, Safoof-e-Bars and Qurs-
e-Suzak showed very good inhibition zone against B. abortus S-19, S. aureus and 
yeast C. albicans while Qurs-e-Sartaan Kafoori shows against S. typhimurium, B. 
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abortus S-19 and yeast, C. albicans respectively. Safoof-e-Kharish showed good 
inhibition zone against B. abortus S-19 followed by S. aureus and Dawa-e-Dibba 
displayed vtry good inhibition zone against S. aureus B. abortus S-19 and yeast, C. 
albicans. Hence, it may be suggested that the fungal infections exists mainly due to 
C. albicans, the patients may be advised to depend on Safoof-e-Bars, Qurs-e-Suzak 
and Dawa-e-Dibba along with other supplements. Those infected with B. abortus S-
19, any of the four Unani formulations except Qurs-e-Sartaan Kafoori may be 
recommended to eliminate the infection. However, the inhibition due to Qurs-e-
Sartaan Kafoori was observed very restricted during the present study, thus its 
limited and confined use against the S. typhimurium stimulated infection is 
advisable. 
2.4. Conclusion 
The tested drugs may be recommended for use against investigated 
pathogens borne diseases wherein considerable inhibition has been noticed such as 
Safoof-e-Kharish, Qurs-e-Sartaan Kafoori and Dawa-e-Dibba. The drugs have 
traditional recommended doses, but their proper intake in evaluated dosages is 
advisable along with other supplementary compounds for complete recovery. 
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Table 2.1 Ingredients of Unani drug Qurs-e-Sartaan Kafoori. 
Unani Name 
Kafoor 
Sandal Safaid 
Sandal Surkh 
Sandal Zard 
Tukhm-e-Kahu 
Samagh-e-Arbi 
Kateera 
Tabasheer 
Gule Surkh 
Mu!athee(Uslussoos) 
Rubussoos 
Nishahta 
Khurfa Siyah 
Magz-e-Tukhm-e- Khairain 
Maghz-e-Tukhm-e-
Kharbooza 
Maghz-e-Tukhm-e- Kaddu 
Tukhme Khaskhas 
Sartaan 
Shakar 
English Name 
Camphor 
Sandal Wood 
Red Sandal Wood 
-
Lettuce 
Babool Gum 
Gum Tragacanth 
Bamboo Manna 
Red Rose 
Sweet Wood 
-
Wheat Exract 
Purslane 
Seeds of Cucumber 
Seeds of Muskmelon 
Seeds of Pumpkin 
Popy Seeds 
Crab 
Sugar 
Scientific Name 
Cinnamomum camphora 
Santalum album Linn 
Pterocarpus santalinus 
-
Lactuca sativa Linn. 
Acacia nilotica 
Cochlospermum reliogiosum 
Bambusa bambos Druce 
Rosa dotnascena Mill. 
Glycyrrhiza glabra Linn. 
-
Triticum aestivum 
Portolae oleracea 
Cucumis sativus 
Cucumis melo 
Cucurbita moschata 
Papaver somniferum 
Callinectes sapidus 
-
Table 2.2 Ingredients of Unani drug Qurs-e-Suzak. 
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Unani Name 
Shoora Qalmi 
Hajrul Yahood 
Sat Barzad 
Raal Safaid 
Sang Jarahat 
Alu-Balu 
Katha Safaid 
Dammul Akhwain 
Kateera 
Bisbasa 
Habbe Kaknaj 
Khar-e-Khask Khurd 
Tabasheer 
Shakh Marjan Sokhta 
Busad Ahmer Sokhta 
Zohar Mohra 
Samagiie Arbi 
Arq Badyan 
English Name 
Lapis Judaicus 
-
Pinus 
White Damar 
-
-
White Catechu 
Dragons Blood 
Gum Tragacanth 
Mace 
White Cherry 
Small Caltrops 
Bamboo Manna 
Coral Branches 
Coral Roots 
Mineral Stone(Serpentine) 
Babool Gum 
Fennel 
Scientific Name 
Potassium Nitrate 
Silicate of Lime 
Pinus longifolia Roxb. 
Valeria indica 
Hydrated magnesium silicate 
Prunus carasus Linn. 
Acacia leucophloea Willd. 
Dracaena cinnabari Balf 
Cochlospermum religiosum 
Myristicafragrance Houtt. 
Physalis alkekenji Linn. 
Tribulus terristeris Linn. 
Bambusa bambos Druce 
Corallium rubrum 
Corallium rubrum 
-
Acacia nilotica 
Foeniculum vulgare Mill. 
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Table 2.3 Ingredients of Unani drug Dawa-e-Dibba. 
Unani Name 
Sibre Zard (Leaves gel) 
Aabe Limu 
English Name 
Aloe Plant 
Lemon 
Scientific Name 
Aloe barbadensis 
Citrus aurentifolia 
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Table 2.4 Ingredients of Unani drug Safoof-e-Bars. 
Unani Name 
Ajmood 
Gairoo 
Surpukha 
Fulfil Siyah 
English Name 
Celery 
Red Ochre 
Purple Teprisia 
Pepper 
Scientific Name 
Apium graveolans Linn. 
Silicate of Aluminium & Iron oxide 
Tephrozia purpuria 
Piper nigrum Linn. 
Table 2.5 Ingredients of Unani drug Safoof-e-Kharish. 
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Unani name 
Kameela 
Murdar Sang 
Safaida Khasgari 
Gandhak 
English name 
Monkey Face Tree 
Massicot 
Flowers of Zinc 
Sulpliur 
Scientific name 
Mallotus philippinemis 
Monoxide of Lead 
Zinc Oxide 
-
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Table 2.6 Amount of crude extracts obtained from each 5 gm of Unani drug. 
Drugs 
Qurs-e-Sartaan Kafoori 
Qurs-e-Suzak 
Dawa-e-Dibba 
Safoof-e-Bars 
Safoof-e-Kharish 
Extract obtained (mg) 
907.5 
644.3 
183.7 
410.8 
175.7 
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Table 2.7 Antibacterial and antifungal activity of the crude extracts of the tested 
drugs*. 
Drugs 
SB 
QSK 
SK 
QS 
DD 
PC 
Blank 
Crude extract 
employed/well 
10 mg 
10 mg 
10 mg 
10 mg 
10 mg 
< 
Antibacterial and antifungal activity in terms of 
zone inhibition (in mm) against test 
microorganisms 
ST 
2+ 
3+ 
-
3+ 
2+ 
4+ 
-
EC 
2+ 
2+ 
-
2+ 
2+ 
3+ 
-
BA 
3+ 
3+ 
4+ 
3+ 
3+ 
5+ 
-
SA 
3+ 
-
3+ 
4+ 
4+ 
4+ 
-
CA 
3+ 
3+ 
2+ 
3+ 
3+ 
2+ 
-
* Drugs key: SB, Safoof-e-Bars; QSK, Qurs-e-Sartaan Kafoori; SK, Safoof-e-
Kharish; QS, Qurs-e-Suzak; DD, Dawa-e-Dibba. Activity key: -, no inhibition; 1+, 
<10 mm zone of inhibition; 2+, 10-15 mm; 3+, 16-20 mm; 4+, 21-25 mm; 5+, 26-
30 mm. Microorganisms key: ST, Salmonella typhimuriun; EC, Escherichia coli; 
BA, Brucella abortus S-19; SA, Staphylococcus aureus; CA, Candida albicans. 
Positive control key: PC, positive control employed/well; Chloramphenicol 20 \ig, 
Salmonella typhimurium; Gentamycin sulphate 100 \xg, Escherichia coli; 
Gentamycin sulphate 30 [ig. Brucella abortus S-19; Chloramphenicol 30 \ig, 
Staphylococcus aureus; Amphotericin B 10 ^ ig, Candida albicans. 
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Table 2.8 Antibacterial and antifungal activity of the crude extracts of the tested 
drugs^ 
Drugs 
SB 
QSK 
SK 
QS 
DD 
PC 
Blank 
Crude extract 
employed/well 
20 mg 
20 mg 
20 mg 
20 mg 
20 mg 
-7 
< 
Antibacterial and antifungal activity in terms of 
zone inhibition (in mm) against test microorganisms 
ST 
3+ 
4+ 
-
3+ 
3+ 
4+ 
-
EC 
2+ 
2+ 
-
3+ 
3+ 
4+ 
-
BA 
4+ 
3+ 
4+ 
3+ 
3+ 
5+ 
-
SA 
NT 
NT 
NT 
NT 
NT 
NT 
NT 
CA 
3+ 
3+ 
2+ 
3+ 
4+ 
3+ 
-
^Drugs key: SB, Safoof-e-Bars; QSK, Qurs-e-Sartaan Kafoori; SK, Safoof-e-
Kharish; QS, Qurs-e-Siizak; DD, Dawa-e-Dibba. Activity key: -, no inhibition; NT, 
not tested; 1+, <10 mm zone of inhibition; 2+, 10-15 mm; 3+, 16-20 mm; 4+, 21-25 
mm; 5+, 26-30 mm. Microorganisms key: ST, Salmonella typhimuriun; EC, 
Escherichia coll; BA, Brucella abortus S-19; SA, Staphylococcus aureus; CA, 
Candida albicans. Positive control key: PC, positive control employed/well; 
Chloramphenicol 20 ^g. Salmonella typhimurium; Gentamycin sulphate 100 pg, 
Escherichia coli; Gentamycin sulphate 30 jig, Brucella abortus S-19; Amphotericin B 
10 ng, Candida albicans. 
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ANTIMICROBIAL ACTIVIT 
HEPATOPROTECTIVE 
EFFECTS OF 
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3. Introduction 
Operculina turpethum (Family: Convolvulaceae), commonly known as 
trivrit or nishot in the Western part of India and adjoining Pakistan, is a plant with 
immense ethno-medicinal value. This plant is widely grown throughout India and it 
is occasionally cultivated in gardens as an ornament. This plant appears to be rarely 
cultivated in non-Indian regions of Asia [Ooststroom, 1953; Verdcourt, 1963; 
Fosberg and Sachet, 1977; Chang 1978] however, it is expected that the medicinal 
use of this plant continued by Indian immigrants. 
O. turpethum is a perennial climber with slender, fleshy and branched roots, 
hard and twisted cord like stem with small ovate leaves [The Wealth of India, 2001]. 
Mainly, roots or stem bark of this plant are traditionally used for medicinal purpose. 
The plant produces two types of roots: sufed or sveta or white roots that are mild, 
and kala or krishna or black roots that give drastic, often poisonous effects [Watt, 
1889]. The root, bark and seeds are reported to contain cardio-active glycosides, 
formerly designated as neriodoprin, neriodorein and karabin which are anti-
inflammator)', stimulant and good pain relievers. Active constituents like P-
sitosterol, a- and P-turpethins, coumarin, scopoletin, lupeol and betulin [Husain et 
al., 1992; Yoganarasimhan, 2000] glycosides, saponins flavonoids, steroids and 
carbohydrates [^^^^ Kumar et al., 2009] have been reported to constitute bulk in 
the plant. O. turpethum extract is used to treat wide range of ailments. For instance, 
it is used to relieve periodic fevers, constipation, flatulence and colic obesity, to treat 
anaemia, splenomegaly, raised lipid levels and obesity [Austin, 1982; Vasudevan, 
1995; Suresh Kumar et al., 2006]. The oil extracted from the root bark is used in 
skin diseases of a scaly nature. The fresh juice of leaves is dropped into the eyes for 
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inducing lachrymation in ophthalmia. It is also reported to use in the treatment of 
piles, tumors and jaundice [Kirtikar and Basu, 1987]. 
In traditional medicine, natural or crude phytoextracts are considered as 
alternative medicines, because some natural constituents present in them 
counterbalance the side effects of synthetic medicines [Ahmad et al., 2008 a]. It is 
therefore obvious that the therapeutic potential and risk efficiency of traditional 
medicinal plants is based on the direct assessment of phytoextracts as well as effects 
of their purified compounds. In case of botanicals also, the benign nature of the 
constituents or their anti-mutagenic potential has to be ensured, since several 
compounds produced within or derived from plants may possess mutagenic potential 
[Ames, 1983; Agner et al., 2001]. Once their benign nature is ensured, anti-
mutagenic/ anti-clastogenic potential of phytoconstituents may also be exploited to 
treat genetic and biochemical ailments. The approach will be at par with that 
employed in cancer treatment, where the protective phytoconstituents were 
consumed as part of the diet or designed remedies [Newman et al., 2003]. Reports 
on anti-mutagenic or anti-clastogenic potential of a number of compounds extracted 
from different plant products are available [Bruni et al., 2006; Barcelos et al., 2007 ]. 
Data are scarce on therapeutic potential of synthetic drugs to treat liver cirrhosis and 
the toxic side effects may remain a persistent risk [Kang et al., 2002; Lotersztajn et 
al., 2005; Kisseleva and Brenner, 2006]. Conversely, the use of a number of natural 
products and phytoextracts has been reported to show negligible or no side effects 
[Austin, 1982; Newman et al., 2003; Colvard et al., 2006; George et al., 2006; Arif 
et al., 2007] against the ill effects produced by many synthetic compounds. 
Therefore, in our opinion, it will be an interesting aspect to evaluate the therapeutic 
potential of 0. turpethum (roots) against those chemical compounds which are of 
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routine use by industrial workers and cause serious damage. One such compound 
selected during the present investigations is A -^Nitrosodimethylamine (NDMA). The 
present study was designed to evaluate whether O. turpethum (roots) aqueous extract 
(OTE) exerts hepatoprotective effects in rats against NDMA induced liver toxicity. 
TV -^Nitrosodimethylamine (NDMA) is a potent hepatotoxin, carcinogen and 
mutagen and it induces fibrosis and cirrhosis of the liver [George and Chandrakasan, 
1996 a; George et al., 2001]. The toxicity produced by NDMA is mediated by its 
reactive metabolites and not by the parent compound. NDMA is used as a softener 
for copolymers production in industries, in addition to synthesis as a chemical 
intermediate in the production of 1, 1-dimethylhydrazine and nematocide [lARC, 
1971]. As a component of tobacco smoke condensate and certain alcoholic 
beverages, NDMA can induce lung, liver or renal cancers [Magee and Barnes, 1967; 
Lijinsky and Epstein, 1970]. 
It has been shown that NDMA induced hepatic fibrosis in rats is a suitable 
and appropriate animal model to study biochemical and pathophysiological 
alterations associated with the development of hepatic fibrosis and alcoholic 
cirrhosis of human [Jenkins et al., 1985; Jezequel et al., 1987; Jezequel et al., 1990; 
George and Chandrakasan, 1996 b; George, 2003]. Hepatic fibrosis is characterized 
by excessive accumulation of connective fissue components, especially matured 
collagen fibers in the extracellular matrix (ECM) of the liver. It is a complex 
dynamic process which reflects the balance between ECM synthesis and degradation 
[Friedman and Bansal, 2006]. The activation of hepatic stellate cells (HSCs) has 
been associated with the pathogenesis of liver fibrosis [Friedman, 2003; Dataller and 
Brenner, 2005]. Activated HSCs are proliferative and fibrogenic and expresses a-
smooth muscle actin (a-SMA) and various connective tissue proteins including 
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collagen type I, III and IV [Pinzani and Marra, 2001; Lotersztajn et al., 2005]. 
Moreover, activated HSCs have been implicated in hepatic inflammation through 
their ability to secrete cytokines, including transforming growth factor-pi (TGF-pi) 
during liver fibrogenesis [Friedman, 2003]. Hepatic fibrosis may be induced by 
various chronic liver injuries including viral and autoimmune hepatitis, alcoholism 
or biliary obstruction [Kisseleva and Brenner, 2006]. In general, fibrosis requires 
years of exposure or sometimes decades to be visible clinically, but few notable 
exceptions are there in which cirrhosis develops in months [Das and Vasudevan, 
2007]. 
In the present study OpercuUna turpethum (roots) aqueous extract (OTE) 
was used for hepatoprotective, antibacterial and antifungal activity. 
3.1. Materials and Methods 
3.1.1. Microbial studies 
3.1.2. Preparation of phytoextract 
Authentic plant material, OpercuUna turpethum, was procured from 
Dawakhana (Pharmacy of Herbal Medicines), Ajmal Khan Tibbiya College, Aligarh 
Muslim University. Following verification of the plant material by an established 
plant taxonomist, some O. turpethum Linn root specimens were stored in the 
Herbarium (Id. No. Cl/94) of Department of Pharmacology (Ilm-ul Advia), Ajmal 
Khan Tibbiya College. Finely ground powder of the dried roots of O. turpethum L. 
(~ 250g) was extracted in distilled water under reflux and filtered on Whatman #1. 
The filtrate was dried in a rotary evaporator at a temperature of 40±1 °C under 
reduced pressure [Harbone, 1973]. The yield of O. turpethum powder from 250g of 
dried roots was ~10-12g. The powder was stored at -2 °C in sterilized and labeled 
screw capped bottles. 
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3.1.3. Microorganisms used 
The test microorganisms included one gram -ve bacterium. Salmonella 
typhimurium (Clinical isolate) and one gram +ve bacterium, Listeria monocytogenes 
(Standard strain) and two fungi, Candida albicans and Cryptococcus neoformans 
(Clinical isolates). 
3.1.4. Culture media 
The media used to grow Candida albicans and Cryptococcus neoformans 
was YPD (Yeast extract, peptone, dextrose) and to culture Salmonella typhimurium 
nutrient broth (NB) was used. Listeria monocytogenes was cultured using brain heart 
infusion agar. All culture media were prepared and treated according to the 
manufacturer's guidelines (Hi-media Pvt. Ltd. India). 
3.1.5. Inoculum 
The microorganisms were inoculated into their respective medium as given 
above. Inoculated broths were kept at 37°C for 12 hours. After 12 hours of 
incubation absorbance was read against sterilized medium (used as Blank) at 580 
nm. Culture was diluted to obtain 1x10^ CFU/ml. 
3.1.6. Antimicrobial susceptibility testing 
The MICs of the Operculina turpethum extract (OTE) for different 
organisms were determined by broth micro dilution method described by National 
committee for clinical laboratory standards [NCCLS, 1995]. The antimicrobial 
agents were tested over the final concentration range of 50 to 0.048 |xg/ml. Tests 
were perfonned in 96 well round bottom microtitre plates. Cell suspensions of 
organisms were prepared to give final inoculums concentration of IxIO^ cells/ml. 
The wells containing microbial inoculum with different concentrations of 
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compounds were incubated for 48 hours. The MIC was defined, as the lowest 
concentration of compound at which there was complete inhibition of growth. 
3.2. Biochemical Toxicology Studies 
3.2.1. Chemicals 
Acrylamide, 3, 3'-Diaminobennzidine tetrahydrochloride hydrate, A^ -
Dimethylnitrosamine, Nicotinamide adenine dinucleotide (P-NAD), Nitro blue 
tetrazolium (NBT), Phenazine methosulphate (PMS) and Trizma base were 
purchased from Sigma-Aldrich, India. Biochemical kits were from Span diagnostics 
Ltd (India), Cyclophosphamide (500 mg Endoxan-N)''"'^  of Baxter Oncology GmbH 
(Germany), Fetal Bovine Serum (FBS) was of Hi-Media, India, Goat anti-mouse 
IgG-HRP conjugated was purchased from CALTAG laboratories, Bangkok, a-
Smooth muscle actin (a-SMA) antibodies were obtained from Trend Bio-products 
Pvt. Ltd., India, All other chemicals used were of analytical grade. 
3.2.2. Animals 
Aduh male albino rats of Wistar strain were kept in well-aerated cages at the 
departmental facility of Zoology department with equal interval of light-dark 
exposure. The rats were acclimatized for a week and fed regularly with sterilized 
diet and water ad libitum. Healthy, 8-10 week old rats weighing around 162 ± 10 g 
were selected for the experiments. 
3.2.3. Induction of hepatic fibrosis 
The animals were divided into 4 groups of 5 each. One group served as the 
negative control and the second group received intraperitoneal injections of normal 
saline. The third group served as the positive control and received intraperitoneal 
injections of cyclophosphamide in their recommended doses. The fourth group was 
administered NDMA intraperitoneally in doses of 10 mg/kg body weight as 
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described previously [George and Chandralcasan, 2000]. The injections were given 
on three consecutive days of each weelc for over 21 days. 
3.2.4. Administration of Operculina turpethum extract (OTE) 
Here also, the experimental animals were divided into 4 groups of 5 each. 
One group served as the OTE control and received OTE alone. The remaining three 
groups received NDMA injections as described above followed by OTE in 
concentrations of 75, 150 and 200 mg/kg body weight OTE was administered after 5 
hours of NDMA administration. The dose of OTE and its administration time was 
selected on the basis of pilot studies [Suresh Kumar et al., 2006]. A set of animals 
from each group were anesthetized with diethyl ether and sacrifice on days 7, 14 and 
21 after the start of NDMA and OTE administrations. Blood was collected from a 
deep cut made on the right jugular vein with a scalpel. Urine was collected under a 
layer of toluene beginning from 24 hours prior to sacrifice. 
3.2.5. Assessment of liver injury 
The process of liver injury and toxicity was assessed through the progression 
of hepatic fibrosis histochemically following staining of serial sections of liver with 
hematoxylin and eosin (H&E). Stained slides were examined under Nikon 
microscope with an LCD attachment (Model: 80/) and photographed. 
3.2.6. Staining of a-smooth muscle actin (a-SMA) 
The degree of hepatic fibrosis was monitored by following activation of 
hepatic stellate cells as indicated by immunohistochemical (IHC) staining of a-
smooth muscle actin (a-SMA) filaments. For detection of a-smooth muscle actin (a-
SMA), serial liver sections (S^m) were stained immunohistochemically using a-
SMA monoclonal antibodies. Peroxidase activity was quenched by incubating the 
sections with 3% hydrogen peroxide for 15-20 min. The sections were washed with 
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Phosphate Buffer Saline (PBS), layered with prediluted monoclonal a-SMA 
antibody and incubated overnight at 2-8 °C in the moist chamber. After washing off 
unbound antibody with PBS for 5 min, the sections were reacted with HRP 
conjugated goat anti-mouse IgG immunoglobulins (secondary antibody) and 
incubated for 30-45 min at room temperature. The slides were washed with cold 
PBS and developed using 3% 3, 3'-diaminobenzidine tetrahydrochloride hydrate 
(DAB) solution for 10-20 min. Developed slides were rinsed with PBS, counter 
stained with Mayer's hematoxylin and mounted with DPX. 
3.2.7, Biochemical parameters 
The commercial kits of Span diagnostics Ltd. (India) were used for 
determination of liver enzymes like alkaline phosphatase (ALP), glutamic 
oxaloacetic transaminase (GOT), glutamic pyruvic transaminase (OPT) and bilirubin 
levels in rat sera. The enzyme activity levels were again verified by using other 
routine laboratory techniques. Hydroxyproline (HP) levels were also estimated in 
sera and urine samples of control and treated group of rats as per previously 
described protocols [Woessner, 1961]. 
Levels of Lactate dehydrogenase (LDH) isoenzymes were analyzed in sera 
and liver homogenates of experimental rats. Livers were homogenized in ice cold 
Tris-HCl buffer (pH, 7.5), centrifuged at 12,000 rpm and -10-15 nl of clear 
supematants were loaded and resolved on native 7.5% vertical slab polyacrylamide 
gel electrophoresis [Ahmad and Hasnain, 2005]. LDH isoenzymes were visualized 
by histochemical staining using L-lactate-PNAD and phenazine methosulphate 
(PMS)-tetrazolium (NBT) protocol [Ahmad et al., 2009]. LDH isoenzyme bands 
developed as purple to dark blue bands at 37°C within 25-30 min. 
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3.2.8. Densitometry 
Quantitative estimates of LDH isoenzyme were made by densitometry of 
enzyme gel-scans using Scion Imaging (Scion Corporation: Beta release-4.0) 
software programs and presented as fractions in arbitrary units (AU) per gram wet 
weight of the tissue. 
3.2.9. Statistical analysis 
The values of selected biochemical markers, hydroxyproline and LDH 
isoenzymes were recorded in their corresponding units and presented as mean ± SD 
(n=5). Analysis of variance (ANOVA) was applied to demonstrate significant 
differences among levels of various liver enzymes. 
3.3. Results 
3.3.1. Microbial 
The results obtained for antimicrobial screening of Operculina turpethum 
extract (OTE) are shown in table-3.1. The antimicrobial activity has been tested 
against one gram-negative bacterium, one gram-positive bacterium and two fungi. 
The results of the screening indicate that OTE possessed good antimicrobial activity 
against the entire tested microorganism. The Operculina turpethum extract (OTE) 
was also observed to inhibit the growth of fungus, Candida albicans at the lowest 
concentration of 6.25(ig/ml. 
3.3.2. Hematoxylin and eosin staining 
3.3.2.1. Histological observations during NDMA treatment and progression of 
hepatic fibrosis 
The hematoxylin and eosin stained slide of liver specimens during NDMA 
administration and progression of hepatic fibrosis is shov.'n in Fig. 3.1. The control 
liver sections showed normal lobular architecture (Fig. 3.1 A). On day-7 
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disintegration of liver parenciiyma, hepatic necrosis and severe centrilobular 
congestion were observed (Fig. 3.1C). Massive hepatic necrosis along with 
neutrophilic infiltration and multifocal collapse of parenchyma were the prominent 
features in liver specimens (sections) of day-14 (Fig. 3.IE). On day-21, NDMA 
treated liver specimens demonstrated disruption of normal liver architecture, 
inflammation, hemorrhage and intensive fibrosis with deposition of thick collagen 
fibers (Fig. 3. IG). At certain places sign of early cirrhosis was also visible. 
3.3.2.2. OTE treatment 
The hematoxylin and eosin staining of liver sections during amelioration by 
OTE is also displayed in Fig. 3.1. The control liver specimens showed normal 
cellular and lobular architecture with radiating hepatic cords (Fig. 3.1 B). A sort of 
fatty change and a low level of Kupffer cells hyperplasia were the peculiar features 
of OTE treated rats on the day-7 (Fig. 3.ID). On day-14, moderate infiltration of 
mononuclear cells and regeneration of hepatocytes was observed in liver sections of 
OTE treated rats (Fig. 3.IF). Remarkable decrease in the hepatic fibrosis was 
visualized on day-21 of OTE treatment (Fig. 3.1H). The liver architecture restored to 
normalize with more number of regenerating hepatocytes. 
3.3.3. Staining of a-smooth muscle actin (a-SMA) 
3.3.3.1. Histological observations during NDMA treatment and progression of 
hepatic fibrosis 
The staining of a-SMA for the visualization of activated hepatic stellate cells 
is demonstrated in Fig. 3.2. In control liver specimens, the a-SMA staining was 
absent (Fig. 3.2A). A large number of a-SMA positive stained stellate cells were 
observed in the necrotic zone on day-7 of treatment with NDMA (Fig. 3.2C). From 
day-7 onwards, the feature of staining of a-SMA was quite persistent. The staining 
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was quite deep (intense) and confined to the fibrotic area in liver specimens on day-
14 (Fig. 3.2E). The count of positively stained hepatic stellate cells further increased 
in the fibrotic zone. On day-21, the a-SMA staining was almost restricted to the 
fibrotic zone (Fig. 3.2G). The number of positive stained cells in the fibrotic area 
was much higher when compared with normal areas of the liver sections. 
3.3.3.2. OTE treatment 
The a-SMA staining in liver specimens of rats treated with NDMA+OTE is 
also shown in Fig. 3.2. Similar to the saline control, the a-SMA staining was also 
absent in OTE control liver samples (Fig. 3.2B). On day-7, focal staining of a-SMA 
around the central vein indicated the ameliorative action of OTE (Fig. 3.2D). In 
liver specimens of day-14, the a-SMA staining was of very low intensity with a few 
numbers of activated stellate cells distributed sporadically (Fig. 3.2F). On day-21, 
the a-SMA staining was almost absent in liver sections of OTE treated rats. This 
indicated restoration of liver parenchyma and regeneration of hepatocytes (Fig. 
3.2H). 
3.3.4. Sera ALP, GOT, GPT and bilirubin levels 
Hepatotoxicity due to MDMA in rats was assessed by the levels of liver 
function enzymes (SALP, SCOT, SGPT) and bilirubin in the sera. As compared to 
their respective control group, significant increase in the activities of SALP, SCOT, 
SGPT (/'<0.05) and bilirubin {P<0.00\) was recorded in rats treated with the 
evaluated doses of NDMA (Table-3.2). Time and dose dependent protection' was 
shown by OTE against NDMA induced hepatotoxicity in rats. Hepatoprotective 
effect of OTE that was evaluated at three different concentrations: 75, 150 and 200 
mg kg"' body weight day"' showed outstanding recovery in LFT values of rats 
receiving 200 mg kg"' body weight day'' of OTE along with NDMA regimen. In 
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comparison with NOMA infused group at this dosage of OTE, significant reduction 
in the levels of SALP, SCOT, SGPT (45.25, 28.94,10.6%) and bilirubin (65.77%) 
was noted (Table-3.2). 
3.3.5. Hydroxyproline levels in the sera and urine 
Hydroxyproline levels were estimated in the sera and urine of NDMA treated 
rats on day-21 of NDMA treatment. The increase of about 20.28 and 57.84% was 
noted in sera and urine hydroxyproline levels, respectively (Table-3.2). Noticeable 
decline in the activity of sera and urine hydroxyproline was observed in rats which 
received OTE regimen (200 mg kg"' body weight day'') for 21 days. In sera and 
urine samples of OTE receiving rats, the decrease in hydroxyproline levels was of 
the magnitude of 16.65 and 47.29%, respectively. 
3.3.6. Total and fractional activity of LDH isoenzymes 
Lactate dehydrogenase (LDH) isoenzymes activity was estimated in the sera 
and liver samples of treated animals and compared with control. The increase in 
total LDH activity was noticed on day-7 onwards in sera samples of NDMA treated 
rats. Particularly, the rise in the activity of LDH-4 and LDH-5 was observed in the 
sera (Fig. 3.3A). OTE treated groups showed significantly decreased levels of sera 
LDH-4 and LDH-5 within 21 days and the ranking of the LDH isoenzymes was 
comparable to the control values (Table-3.3). 
In liver samples of NDMA injected animals, an increase in the levels of 
LDH-4 was observed on day-7, while LDH-5 was detected in significantly higher 
levels at all the selected durations (Fig. 3.3B). On day-21, the ranking of LDH 
isoenzymes was LDH-5>-4>-3>-l>-2 as compared with the control (LDH-5>-4>-
3>-2>-l). Treatment with OTE remarkably reduced the levels of LDH-4 and -5 in 
liver samples of rats at all the durations. On day-21 of OTE treatment, LDH 
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isoenzymes ranking in liver samples was observed LDH-5>-4>-3>-2>-l which was 
exactly similar to control values (Table-3.4). 
3.4. Discussion 
We obtained encouraging results of antimicrobial activity of Operculina 
turpethum extract (OTE), with its activity against all the tested bacteria and fungi. 
Evidence suggests that even in the alcoholic extracts of fresh roots of O. turpethum 
antibacterial activity is present [The Wealth of India, 2001]. The extract was 
observed to inhibit the growth of S. typhimurium and L. monocytogenes at a 
concentration of 50ng/ml, while that of C. albicans successful inhibition was 
obtained at 6.25ng/ml. The growth of C. neoformans was inhibited at a higher 
concentration (>100 ng/ml) of OTE. It is presumed that compared with other routine 
methods being used to ameliorate the common ailments, method of treating with 
effective natural compounds is preferred [Ahmad et al., 2008 a]. 
The biochemical and molecular data obtained during the present study 
strongly support to hepatic fibrosis and cirrhosis-inducing potential of JV-
Nitrosodimethylamine (NDMA) in rats [George and Chandrakasan, 1996 a; George 
and Chandrakasan, 1996 b; George and Chandrakasan, 2000; George et al., 2001; 
George, 2003; Das and Vasudevan, 2007]. The consequent histological and 
biochemical alterations include increased synthesis and deposition of connective 
tissue proteins, changes in hepatic architecture and concomitant impairment of 
several biochemical processes [Jenkins et al., 1985; Savolainen et al., 1988] leading 
to shrunken liver. For the first time we report that aqueous extract of O. turpethum 
root (OTE) can protect NDMA-induced toxic effects on liver. OTE treatment 
restored normal lobular architecture of the liver through extensive regeneration of 
hepatocytes and recovery of biochemical processes. 
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We have taken up two aspects of histopathological changes in liver tissue: (i) 
the changes which can be observed after hematoxyHn and eosin (H&E) staining and, 
(ii) those detectable by immunohistochemical (IHC) staining for the expression of a-
smooth muscle actin (a-SMA). H&E stained liver sections show synthesis as well as 
continued accumulation of collagen in liver from the day-7 onwards. In fact, by day-
21 post-treatment with NDMA, complete architecture of the liver deteriorated. 
During hepatic fibrosis, the role of activated stellate cells in excessive collagen 
synthesis is well established [Brenner et al., 2000; Das and Vasudevan, 2007; 
George, 2008]. OTE administration in rats significantly reduced the inflammation, 
necrosis and fibrotic area produced during NDMA induced hepatic fibrosis. The 
reversal in necrosis and hepatic fibrosis due to the treatment with OTE was most 
remarkable on day-14 and 21. 
The expression of a-smooth muscle actin (a-SMA) by the stellate cells (SCs) 
is considered as the most reliable marker for activated hepatic stellate cells which 
add to collagenous connective tissue [Rockey et al., 1992]. The presence of high 
number of activated SCs on day-7 of NDMA administration indicates that the 
fibrosis had started much before day-7 [George and Chandrakasan, 1996 b; George 
and Chandrakasan, 2000; George et al., 2001]. The late stage of hepatic fibrosis and 
cirrhosis was characterized by more enhanced expression of a-SMA in the activated 
SCs in the fibrotic area on day-14 and 21, respectively. OTE treatment caused 
constant decline in the density of activated SCs on day-7 and 14. Antifibrotic and 
hepatoprotective potential of OTE is evident by a decline in the a-SMA staining and 
increase hepatocytes regeneration on day-21 indicating the elimination of activated 
hepatic SCs. 
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Similar to previously published reports [George and Chandraicasan, 1997; El-
Zayat, 2007], we also recorded significant increases in total LDH activity in sera 
with major contribution of LDH-4 and LDH-5 isoenzymes. These changes begin on 
day-7 and become more intense on day-14 and 21. The initial increase has been 
attributed to an increase in the synthesis of LDH due to the presence of higher 
number of fiinctional hepatocytes during early fibrosis [George and Chandrakasan, 
1997]. However, the increase in LDH levels at advanced stage of fibrosis appears to 
be the consequence of tissue injury and necrosis leading to leakage of the enzymes 
into blood stream [George and Chandrakasan, 1997; Ahmad et al., 2008 b; Ahmad et 
al., 2009]. That the enzymatic changes may actually be the result of cellular injury is 
supported by our histopathological data with the changes in enzyme and isoenzyme 
levels. While the induction of fibrosis by NDMA disrupts cellular architecture of 
liver tissue, which is also collateral to elevated enzyme levels, OTE significantly 
reverses all of these changes. 
No report is available on the hepatoprotective effect of OTE against NDMA 
induced liver injury in rats, though its use as hepatoprotectant against paracetamol-
induced toxicity [Suresh Kumar et al., 2006] and in other clinical and pathological 
conditions has been recognized [Austin, 1982; The Wealth of India, 2001]. 
According to the present data, the protection provided by OTE against NDMA-
induced hepatotoxicity was time as well as dose dependent. OTE at 200 mg kg'' 
body weight of rat for 21 days reduced the levels of hydroxyproline (sera/urine), 
SALP, SGPT, SGOT and total bilirubin up to 16.65, 47.29 (P<0.001), 45.25, 10.6, 
28.94 (P<0.05) and 65.77% (/'<0.001), respectively. The values in NDMA treated 
rats on day-21 showed an increase of 20.28, 57.84, 55.72, 13.84, 33.68, 78.79 % in 
sera, urine hydroxyproline, SALP, SGPT, SGOT levels and bilirubin, respectively. 
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This trend of increase is in agreement with the observations made earlier [George 
and Chandrakasan, 2000; George et al., 2001]. 
The present study demonstrates that liver detoxification and the prevention 
of collagen accumulation are simultaneous processes. This is evident from the 
correspondence between histopathological observations of OTE treated rat livers and 
the shift in sera ALP, GPT, GOT, LDH isoenzymes and bilirubin levels towards 
control values. That there occurs lesser hydrolysis of collagen in OTE injected rats 
on day-21 Is evident by lower hydroxyproline levels, which indicates reduced spill 
of this non-essential amino acid in the sera/urine. Obviously, OTE restores 
hydroxyproline levels by blocking the pathways to collagenesis. An increase in 
hepatic collagenolytic enzymes and liver function test enzymes has been recorded in 
cases of carbon tetrachloride-induced early fibrosis [Murawaki et al., 1990; Hall et 
al., 1991] and the patients with chronic liver injuries [Murawaki and Hirayama, 
1980]. 
3.5. Conclusion 
The present study thus, suggests that 0. turpethum (roots) aqueous extract 
(OTE) shows hepatoprotective effects by decreasing collagen contents, restoring a-
SMA activity and enzyme markers of the liver injury. Therefore it is advisable that 
OTE in its maximum evaluated dose may be potentially useful in preventing liver 
injuries in particular NDMA induced fibrosis. 
Moreover, the extract also shows remedial effect against Salmonella 
typhimurium, Listeria monocytogenes, Candida albicans and Cryptococcus 
neoformans. Therefore may also be used to combat tested pathogenic borne 
infection. 
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Table 3.1 Antimicrobial activity of Operculina turpethum. 
Microorganisms 
Salmonella typhimurium 
Listeria monocytogenes 
Candida albicans 
Cryptococcus neoformans 
Minimum inhibitory concentration in fig/ml 
OTE 
50 
50 
6.25 
>]00 
Positive control 
1.25 
2.0 
0.25 
0.06 
OTE = Operculina turpethum extract, positive control ; Gentamicin (Salmonella 
typhimurium. Listeria monocytogenes) and Amphotericin B {Candida albicans, 
Cryptococcus neoformans) 
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NDMA+OTE 
Fig. 3.1 Hematoxylin and Eosin (H&E) staining of rat liver sections during the 
pathogenesis of NDMA induced hepatic fibrosis and concurrent administration of 
OTE. (A) Control liver (xI25). (B) OTE control (xl25). OTE was administered 200 
mg/kg body weight (C) NDMA, Day 7 (xI25). Severe centrilobular congestion 
(arrow) and hemorrhagic necrosis. (D) NDMA + OTE, Day 7 (x250). Kupifer cells 
hyperplasia and fatty changes. (E). NDMA, Day 14 (xl25). Massive hepatic 
necrosis (arrow), severe neutrophilic infiltration and multifocal collapse of liver 
parenchyma. (F) NDMA + OTE, Day 14 (^125). Moderate infiltrafion of 
mononuclear cells and regenerafion of hepatocytes. (G) NDMA, Day 21 (xl25). 
Marked hepatic fibrosis (arrow) and deposition of collagen fibers. (H) NDMA + 
OTE, Day 21 (x250). Restoration of normal liver architecture with increased 
number of regenerating hepatocytes. 
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NOMA NDMA+OTE 
Fig. 3.2 Immunohistochemical staining of a-smooth muscle actin (a-SMA) 
demonstrating activated hepatic stellate cells during the pathogenesis of NDMA 
induced hepatic fibrosis and ameliorating effects of OTE (A) Control liver (xlOO). 
Absence of a-SMA staining. (B) OTE control (xlOO). OTE was administered 200 
mg/kg body weight. a-SMA staining is absent. (C) NDMA Day 7 (xlOO). Staining 
of a-SMA demonstrates activated hepatic stellate cells in the necrotic zone. (D) 
NDMA + OTE, Day 7 (x250). Focal staining of a-SMA around central vein 
indicating ameliorative effects of OTE. (E). NDMA, Day 14 (xlOO). Intense 
staining of a-SMA indicating extensive activation of hepatic stellate cells in the 
fibrotic zone. (F) NDMA + OTE, Day 14 (xlOO). Mild staining of a-SMA (G) 
NDMA, Day 21 (x200). Remarkable staining of a-SMA demonstrating enormous 
number of activated stellate cells in fibrotic zone. (H) NDMA + OTE, Day 21 
(x250). Absence of a-SMA staining and restoration of normal liver parenchyma 
with regeneration of hepatocytes. 
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Fig. 3.3 Polyacrylamide gel electrophoretic (PAGE) pattern of lactate 
dehydrogenase (LDH) isoenzymes in the serum (A) and liver homogenate (B) 
during the pathogenesis of NDMA induced hepatic fibrosis and concurrent 
administration of OTE in rats. 
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4. Introduction 
Acacia leucophloea Willd. (Syn. A. alba Willd., Family Mimosaceae) 
commonly kjiown as Safed Kikar is a moderate- sized deciduous tree, found in the 
plains of Punjab, central India, Andhra Pradesh, Karnataka, Rajasthan and dry region 
of peninsular India and is also found in the dry zones of Burma [Maheswari, 1963; 
Anonymous, 1985]. 
The plant has been described for astringent, demulcent, aphrodisiac and other 
medicinal uses, like treatment of traumatic ulcer and antisyphilitic agent [Chopra et 
al., 1965; Nadkami and Nadkami, 1966; Anonymous, 1985; Khan et al., 1990; Khan 
et al., 1991]. The bark extract is use as contraceptive and for menstrual problems 
[Anita et al., 2004] and alcoholic extract of air dried heart wood powder possesses 
antibacterial activity [Javed, 1990]. The plant has been reported for juvenomimetic 
activity [Javed, 1990]. 
Isoprene, a - pinene and many other volatile organic compounds (VOC), 
moderately emitted from the plant. [Padhey and Varshney, 2005]. The volatile organic 
compounds have a great deal in atmospheric chemistry [Haagen-Smit et al., 1953; 
Dodge 1984; Derwent 1999]. Among the volatile organic compounds Isoprene is 
? 
highly reactive species and has a great tendency to ozone formation [Dollard et al., 
1997]. 
Devi and Prasad (1991) quantitatively determined the presence of tannins and 
related polyphenols from the leaf, bark and pods of the plant. 
Tannins and polyphenols are the very important class of natural products 
having great variation in their structure and phylogenetic distribution. Tannins are 
very much important for leather industries as raw material to tan the hides and for 
many other industrial applications [Edwards et al., 1952; Howes, 1953; McBride, 1983]. 
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Kapoor et al., (1971) have reported the following seed analysis: ^^ o^ister 71%, 
protein 27.4%, pentosan 12.8%), water soluble mucilage 7.1%) and protein in mucilage 
29.0% and the oil composition of seeds was reported by [Javed, 1990] with the 
characteristics saponification value 193.4-194.9%), iodine value 110.3-111.2%), 
percentage of oil 12.61, acid value 1.0-1.1, ester value 193.8-194.4%), specific gravity 
d/''=1.108; viscosity E at 32°C - 64.5, moister 6.04%, ash content 1.04%), optical 
activity - no rotation in 2%o solution of CHCI3, soluble in organic solvents and 
charring with cone. H2SO4. The effect of temperature on viscosity of the oil was also 
studied. The soap prepared from its oil was found to be similar to the soaps prepared 
from edible oils. 
Literature survey revealed that the plant has been examined for chemical 
constituents and the constituents isolated from the different part of the plant listed 
below. 
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Part of the 
plant 
Flowers 
Flowers 
Flowers 
Pods 
Leaves and 
pods 
Stem Bark 
Stem Bark 
Heart wood 
Heart wood 
Root bark 
Roots 
Roots 
Compounds isolated 
Behenic ester, p- Sitosterol, Quercetin-3-glucoside, Mannitol 
Myricitin, Quercetin, 3'-Hydroxy-7-methoxyisoflavone, 
Apegenin, 8-c-Glucoside of Apegenin. 
Octacosane, Trloacontane, Triacontanol, (+)- Pinitol, Gallic 
and p-Hydroxybenzoic acid, Methyl gallate, Kaempferol, 
Quercetin, Quercetrin, Rutin. 
P" Sitosterol, Luteolin, Mannitol 
Hydrocyanic acid 
n-Hexacosanol, P- Sitosterol, p-Amyrin 
Isookanin, Cyanin, Leucodelphinidin -3-0- a-L-
rhamnopyranoside, Delphinidin 
P" Sitosterol, n-Octacosanol 
Octacosanol, (+)- Pinitol 
Leucophleol, Leucophleoxol, Leucoxo! 
l,3-Dihydroxy-5-methoxy-2-methylanthraquinone-8-0- a -
L-rhamnopyranoside, l-Hydroxy-8-methoxy-2-
methylanthraquinone-3-O-a-L- rhamnopyranoside, 1,5-
Dihydroxy-8-methoxy-2-methylanthraquinone-3-0-a-L 
rhamnopyranoside, Galangin-3-O-a-L- rhamnopyranoside 
Betulinic acid-3-O-P-D-maltoside 
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H.,C- ,C00. -CH, 
Behenic ester 
p- Sitosterol 
Quercetin-3- glucoside 
HO-
HO-
H-
H-
CH2OH 
-H 
-H 
-OH 
-OH 
CH2OH 
Mannitol 
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Quercetin 
H3CO 
3'-Hydroxy-7-methoxy isoflavone 
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OH 0 
8-c-Glucoside of Apegenin 
H,C-
H,C 
H,C. 
Octacosane 
Triacontane 
Triacontanol 
coh ^
 
(+)- Pinitol 
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COOH 
HO' T OH 
OH 
Gallic acid 
COOH 
OH 
Para hydroxy! benzoic acid 
HO' " T 'OH 
OH 
Methyl gallate 
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OH OH 
Rutin 
Luteolin 
H,C 3 " - \ 
Hexacosanol 
^CHzOH 
74 
(3- Amyrin 
Cyanin 
OH OH 
Leucodelphinidin-3 -o- a-L-rhamnopyranoside 
Delphinidin 
75 
H,C' 
XH2OH 
Octacosanol 
OH 
- J<'^ OH r T^CHzOH 
Leucophleol 
Leucophleoxol 
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J'"OH 
Leucoxol 
OCHP 
l,3-Dihydroxy-5-methoxy-2-methylanthraquinone-3-o-a-L-rhamnopyranoside 
OCHp OH 
OH OH 
1- Hydroxy-8 -methoxy-2-methylanthraquinone-3-o- a-L-rhamnopyranoside 
OCHP OH 
OH OH 
1,5-Hihydroxy-8-methoxy-2-methylanthraquinone-3-o-a-L-rhamnopyranoside 
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OH OH 
Galangin-3-o-a-L-rhamnopyranoside 
COOH 
Betulinic acid 3-o-P-D-maltoside 
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The bark of the plant is used as one of the ingredients in Unani medicine for 
Gonorrhoea "Qurse-e-suzaPc" manufactured and mariceted by Dawalchana Ajmai Khan 
Tibbiya College Aligarh Muslim University, Aligarh, India [Patent]. The use of bark 
in herbal preparations prompted us to investigate the antimicrobial activity as well as 
their phytoconstituents. 
4.1. Materials and Methods 
4.1.1. Plant material 
The stem bark of the Acacia leucophloea Willd. was collected from the Gir 
forest Gujarat, India in the month of August 2005 and identified by Dr. Athar Ali 
Khan (Taxonomist) and logged in Department of Botany, Aligarh Muslim University, 
Aligarh with the voucher specimen NO. 943. 
4.1.2. Preparation of plant extract and column chromatography 
The air dried bark 1.64 Kg was exhaustively extracted with ethanol. The crude 
extract was evaporated in vacuum to yield dark brown crude product. The crude 
product was successively fractionated with chloroform, ethyl acetate, acetone and 
ethanol till the solvent in each case was almost colorless. Each fraction was 
concentrated to dryness under reduced pressure and leveled as AL-2, AL-3, AL-4 and 
AL-5 and kept at 4 °C in screw capped bottled for further use. 
The ethyl acetate fraction (AL-3) 54.9 gm was adsorbed on silica gel and 
passed over a column of silica gel (3 cm d x 120 cm.) set with petroleum ether. The 
column was eluted with petroleum ether, chloroform, chloroform: ethyl acetate 
(20:80, 50:50), ethyl acetate, ethyl acetate: acetone (50:50), acetone and methanol. 
The fractions were monitored by TLC examination using different solvents 
system and the same fractions were mixed together on the basis of TLC pattern. The 
fractions obtained from petroleum ether and chloroform were found waxy so further 
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studies on these fractions were abandoned. The fractions obtained from chloroform : 
ethyl acetate (20:80, 50:50), ethyl acetate, ethyl acetate : acetone (50:50), acetone and 
methanol were taken under consideration for antimicrobial activity and phytochemical 
investigation and labeled as A-1 (chloroform : ethyl acetate, 20:80) A-2 (chloroform : 
ethyl acetate, 50:50), A-3, A-4, A-5 and A-6 (ethyl acetate), A-7 (ethyl acetate : 
acetone 50:50), A-8 (acetone), A-9 (methanol). 
The column chromatography of ethyl acetate fraction of Acacia leucophloea 
Willd. bark extract afforded a fairly pure fraction, A-4. The 'H-NMR spectra of the 
A-4 was very complex therefore the fraction A-4 was subjected to further purification 
by preparative HPLC using C-18 column (30 X 250 mm). The pre-purified compound 
was analyzed by UPLC-MS (Fig 4.1) for purity using gradient system: Column BEH 
C-18 (2.1 X 100 mm) 1.7 ,^ Mobile phase A 0.1% HCOOH (Aq.) and B Acetonitrile 
(0.1% HCOOH), T% B: 0/03, 0.1/03, 1.4/100.0, 1.9/100.2, Diluent: methanol. 
The purified fraction was subjected to mass spectrometry and NMR ( 'H-NMR 
and '^ C-NMR. 
4.2. Microbial study 
4.2.1. Microorganisms used 
The test microorganisms included one gram -ve bacterium Salmonella 
typhimurium (Clinical isolate) and one gram +ve bacterium Listeria monocytogenes 
(standard strain) and two fungi, Candida albicans and Cryptococcus neoformans 
(Clinical isolates). 
4.2.2. Culture media 
The medium used to grow Candida albicans and Cryptococcus neoformans 
was YPD (Yeast extract, peptone, dextrose) and to culture Salmonella typhimurium 
nutrient broth was used. Listeria monocytogenes was cultured using brain heart 
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infusion agar. All culture media was prepared and treated according to the 
manufacturer's guidelines. (Hi-media Pvt.Ltd. India). 
4.2.3. Inoculum 
The microorganisms were inoculated into their respective medium as given 
above. Inoculated broths were kept at 37°C for 12 hours. After 12 hours of incubation 
absorbance was read against sterilized medium at 580 nm. Culture was diluted to 
obtain IX 10^  CFU/ml. 
4.2.4. Antimicrobial susceptibility testing 
The MICs of the fractions for different organisms were determined by broth 
micro dilution method described by National Committee for Clinical Laboratory 
Standards (NCCLS, 1995). The antimicrobial agents were tested over the final 
concentration range of 50 to 0.048 fig/ml. Testing was performed in 96 well round 
bottom microtitre plates. Cell suspensions of organisms were prepared to give a final 
inoculum concentration of 1 X 10^  cells/ml. The wells containing microbial inoculum 
with different concentrations of compounds were incubated for 48 hours. The MIC 
was defined, as the lowest concentration of compound at which there was complete 
inhibition of growth. 
4.3. Results 
4,3.1. Microbial 
The results of the antimicrobial screening of the fractions obtained from 
ethanolic extract as well as the fractions obtained from column chromatography are 
shown in table- 4.1 and 4.2 respectively. The results obtained are highly encouraging. 
From the table 4.1 it seems very clear that ethyl acetate fraction (AL -3) inhibit the 
growth of all the tested microorganisms. 
Among the microorganisms used Listeria monocytogenes and Cryptococcus 
neoformans shows good sensitivity against all the fractions. The chloroform fraction 
does not inhibit the growth of Candida albicans while ethanol and acetone fractions 
does not show activity towards Salmonella typhimurium. 
From the table-4.2 we can observed that the fractions obtained from column 
(Al to A9) shows activity against all the tested microorganism. 
4.3.2. Spectral analysis 
The mass spectrum of A-4 is given in Fig. 4.2 and Fig. 4.3 and ' H - N M R is 
given in Fig.4.4 and Fig. 4.5. The '''C-NMR is given in Fig.4.6. The results are 
summarized below: 
ESl-MS: Positive ion mode [M+Hf m/z 835.5, 683.8, 563.7, 545.6 
ESI-MS: Negative ion mode [M-H]' m/z 833.3, 561.1, 152.7 
' H - N M R : Protons 5 6.92-6.08, 13H (m, br), 4.85-4.32, 6H (m, br), 4.23-4.04 3H 
(m), 2.94-2.45 3H (m). 
'^C-NMR: 5 157.8, 156.8, 156.4, 155.5, 146.0, 145.6, 145.3, 132.3, 132.0, 129.8, 
121.0, 120.7, 19.4, 115.9, 113.3, 109.2, 103.6,84.5,84.2,82.1,72.1,71.5,68.5,42.5, 
30.6, 30.4 
The above spectral data support the following structure for A-4. 
A-4 
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562,1 
Chart 4.1 
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4.4. Discussion 
Ethnopharmacologists, botanists, microbiologists, and natural-products 
chemists are collaborating with each other for phytochemicals and engaged to develop 
the safer alternatives for the treatment of infectious diseases [Cowan, 1999]. 
Historical evidences suggested that plants have provided a natural source of 
antiinfective agents; emetine, quinine, and berberine remain highly effective 
phytoproducts towards microbial infections. Phytomedicines derived from plants have 
shown great promise in the treatment of intractable infectious diseases including 
opportunistic AIDS infections [Iwu et al., 1999]. 
In the present study efforts are made to evaluate the antimicrobial activity and 
phytochemical investigation of the Acacia leucophloea Willd. stem bark as it is used 
in the herbal preparations. The antimicrobial activity of fractions obtained from the 
ethanolic extract and the fractions obtained from column chromatography in terms of 
minimum inhibitory concentration was assessed by micro dilution method as 
suggested by National Committee for Clinical Laboratory Standards [NCCLS, 1995]. 
Among the fractions obtained from ethanolic extract the ethyl acetate fraction 
shows remarkable activity against entire tested microorganisms. 
Among the microorganisms used Salmonella typhimurium does not sensitive 
against acetone and ethanol fraction but shows sensitivity against ethyl acetate 
fraction and it inhibit the growth at a very low concentration of 12.5ng/ml. All the 
fractions inhibit the fungal growth except chloroform fraction which does not show 
activity against Candida albicans. All the fractions are active against Listeria 
monocytogenes and Cryptococcus neoformans. The acetone fraction inhibits the 
growth oi Candida albicans at a very low concentration of 6.25 |ig/ml as compared to 
all other tested microorganisms. 
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Since ethyl acetate fraction showed activity against all the microorganisms 
used, it was further fractionated by column chromatography. 
The results of the screening of antimicrobial activity of fractions obtained 
from column chromatography also displayed good activity against all the tested 
microorganisms. All these fractions inhibit the growth of tested microorganisms.The 
fraction A-1 inhibit the growth of yeast Candida albicans at the lowest concentration 
of 25 ng/ml. Fractions A-3 and A-8 inhibit the growth of Salmonella typhimurium and 
Listeria monocytogenes at the concentration of 25 ng/ml. while other fractions inhibit 
the growth of microorganisms at the minimum concentration of 50 ng/ml and 100 
Jig/ml. 
The partially purified fractions (A1-A9) obtained from ethyl acetate fraction of 
crude extract show inhibition at higher concentration compared to ethyl acetate 
fraction itself. For example ethyl acetate extract (AL-3) inhibit the growth of 
Salmonella typhimurium and Listeria monocytogenes at a concentration of 12.5 ng/ml 
while partially purified fraction A-3 and A-8 inhibit at lowest concentration of 25 
Hg/ml. Similarly A-1 inhibit the growth of Candida albicans at concentration of 25 
^g/ml. Therefore the more inhibitory activity was observed in ethyl acetate fraction of 
crude extract compared to partially purified compound may be attributed to synergic 
effect. 
As the literature survey revealed that plant is rich in tannins and related poly 
phenols [Devi and Prasad 1991]. The compound isolated (A-4) from the stem bark of the 
plant is very much related to condensed tannins. The condensed tannins are the 
oligomeric and polymeric proanthocyanidins formed by the linkage of C-4 of one 
catechin unit with C-8 or C-6 of the next monomeric catechin unit. [Khanbabaee and Ree 
2001]. However, the structure of trimeric, tetrameric and higher oligimeric procyanidins 
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not yet fully known [Nonaka et al., 1981]. In the compound A-4, a new linkage between 
monomeric catechin units is observe that is C-5 of one catechin unit linked with C-8 of 
next catechin unit. This linkage was confirmed by the mass fragmentation (Chart 4.1). 
The molecular ion peak of exact mass 834, appears in both positive and 
negative ion mode so it confirms the molecular weight of the molecule. The m/z ion 
appearing at 835.5, 683.8, 563.7, 545.6 in positive ion mode and 833.3, 561.1, 152.7 
in negative ion mode suggest the trimeric structure of the compound, A-4. 
The 'H N M R and '^ C-NMR were run on a Varian 400 MHz instrument; 
spectra were taken in methanol and tetramethylsilane as the internal standard. 
Proton NMR spectra showed the phenylic protons at 5 6.92-6.08 as a multiplet 
while the benzylic protons of C-4 carbons and C-2 carbons appeared at 5 4.85-4.32 as 
a multiplet another set of benzylic protons of C-4 carbons appeared at 5 2.94-2.45 as 
multiplet. The remaining protons of C-3 carbons appeared along with benzylic 
protons at 5 4.23-4.04 as multiplet [Nonaka et al, 1981; Stafford et al, 1985; Ozawa et 
al, 1990; Khanbabaee and Ree, 2001]. 
The structure was further supported by the appropriate resonance in the C-
NMR spectrum (5 157.8, 156.8,156.4,155.5, 146.0, 145.6, 145.3, 132.3, 132.0, 129.8, 
121.0, 120.7, 19.4, 115.9, 113.3, 109.2, 103.6,84.5,84.2,82.1,72.1,71.5,68.5,42.5, 
30.6, 30.4). 
4.5. Conclusion 
It may be concluded that the crude extracts rich in plant polyphenolics show 
better antibacterial and antifungal activity compared to purified fractions. Therefore, 
crude extract may be advisable for the treatment of tested pathogenic microorganisms 
borne diseases. 
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Table 4.1 Antimicrobial activity of the fractions obtained from ethanolic extract of 
Acacia leucophloea Wiild. stem bark. 
Microorganisms 
Salmonella 
typhimurium 
Listeria 
monocytogenes 
Candida 
albicans 
Cryptococcus 
neoformans 
Minimum inhibitory concentration in ^ .g 
AL-2 
25 
25 
-
>100 
Fractions* 
AL-3 
12.5 
100 
12.5 
>50 
AL-4 
-
50 
6.25 
>25 
AL-5 
-
25 
25 
>100 
/ml 
Positive 
control 
1.25 
2.0 
0.25 
0.06 
"Fractions key: AL-2 = Chloroform fraction, AL-3 = Ethyl acetate fraction, 
AL-4 = Acetone fraction, AL-5 = Ethanol fraction, - = No activity, positive control; 
Gentamicin {Salmonella typhimurium. Listeria monocytogenes) and Amphotericin 
B {Candida albicans, Cryptococcus neoformans) 
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Table 4.2 Antimicrobial activity of the fractions obtained from column chromatography of ethyl 
acetate fraction of Acacia leucophloea Willd. stem bark extract. 
Microorganisms 
Salmonella 
typhimuhum 
Listeria 
monocytogenes 
Candida 
albicans 
Cryptococcus 
neoformans 
Minimum inhibitory concentration in ;ig/ml 
Fractions* 
A-1 
50 
50 
25 
50 
A-2 
50 
100 
100 
100 
A-3 
25 
25 
50 
50 
A-4 
50 
50 
50 
50 
A-5 
50 
50 
50 
50 
A-6 
50 
50 
100 
100 
A-7 
50 
50 
50 
50 
A-8 
25 
25 
50 
50 
A-9 
50 
100 
50 
50 
Positive 
control 
1.25 
2.0 
0.25 
0.06 
'Fractions key: A-1 (CHCI3: Ethyl acetate, 20:80) A-2 (.CHCI3 : Ethyl acetate, 50:50), A-3, A-4, 
A-5 and A-6 (Ethyl acetate), A-7 (Ethyl acetate : Acetone 50:50), A-8 (Acetone ), A-9 
(Methanol). Positive control; Gentamicin (Salmonella typhimurium. Listeria monocytogenes) and 
Amphotericin B {Candida albicans. Cryptococcus neoformans). 
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